JB Chemicals & Pharmaceuticals Ltd.

•

jbpharma.comBSE: 506943NSE: JBCHEPHARM

Market Cap₹ 38,731 Cr.

Current Price

High / Low₹ 2,526 / 1,638

Stock P/E0.0

Book Value₹ 251

Dividend Yield0.91 %

ROCE24.5 %

ROE18.6 %

Face Value₹ 1

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

No analysis found

We don't have this information yet. Please check back later.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	Sun Pharmaceutical Industries Ltd.	1950.00	40.76	467870.32	0.82	2709.66	25.80	14611.79	12.76	19.11	26.97
2.	Divi's Laboratories Ltd.	7319.75	75.67	194316.36	0.41	751.00	13.44	2831.00	9.52	21.51	32.99
3.	Torrent Pharmaceuticals Ltd.	5002.75	78.26	169315.79	0.76	364.00	-26.91	4197.00	41.84	19.27	32.31
4.	Cipla Ltd.	1429.45	29.77	115477.45	0.91	542.51	-55.32	6541.20	-2.80	16.00	15.13
5.	Zydus Lifesciences Ltd.	1153.50	22.83	115062.07	0.09	1341.00	7.82	7587.00	16.22	21.39	25.16
6.	Lupin Ltd.	2500.05	21.44	114311.01	0.72	1468.67	87.72	7474.66	31.89	28.86	33.25
7.	Mankind Pharma Ltd.	2545.00	54.95	105107.48	0.00	559.42	31.74	3442.93	11.81	13.24	27.10
8.	Dr. Reddy's Laboratories Ltd.	1223.90	24.35	102155.97	0.65	221.30	-86.05	7546.40	-11.51	13.75	5.13
9.	Aurobindo Pharma Ltd.	1548.10	25.42	89074.25	0.26	920.84	1.99	8853.34	5.62	14.39	19.77
10.	Laurus Labs Ltd.	1557.60	94.68	84149.28	0.13	282.09	21.19	1811.57	5.31	18.20	28.28
11.	Biocon Ltd.	440.70	186.26	71820.62	0.11	198.60	-56.77	4516.60	2.25	3.26	22.59
12.	Alkem Laboratories Ltd.	5703.50	29.63	68193.90	0.93	251.11	-22.11	3603.32	14.62	21.56	14.34

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales	1,004	1,001	963	949	1,094	1,085	1,065	904
	724	730	709	723	793	775	769	703
Operating Profit	280	271	255	226	301	310	296	201
OPM %	28%	27%	26%	24%	28%	29%	28%	22%
	6	10	8	14	15	15	18	-15
Interest	6	2	3	1	1	1	2	1
Depreciation	41	42	42	46	43	44	45	50
Profit before tax	240	237	218	193	272	279	267	135
Tax %	26%	26%	25%	25%	25%	26%	26%	25%
Net Profit	177	175	162	146	202	208	198	101
EPS in Rs	11.39	11.24	10.45	9.36	12.96	13.27	12.63	6.31

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2024	Mar 2025	Mar 2026
Sales	3,29,864	3,72,292	3,88,989
	2,42,157	2,70,765	2,83,794
Operating Profit	87,708	1,01,527	1,05,195
OPM %	27%	27%	27%
	3,702	3,740	5,923
Interest	4,052	912	459
Depreciation	13,524	16,645	17,669
Profit before tax	73,834	87,711	90,273
Tax %	26%	26%	25%
Net Profit	54,336	65,254	67,410
EPS in Rs	35.07	42.00	42.91

COMPOUNDED SALES GROWTH

10 Years:: —
5 Years:: —
3 Years:: —

COMPOUNDED PROFIT GROWTH

10 Years:: —
5 Years:: —
3 Years:: —

STOCK PRICE CAGR

5 Years:: —
3 Years:: —
1 Year:: —

RETURN ON EQUITY

Last Year:: 19%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2024	Mar 2025	Mar 2026
Equity Capital	1,552	1,557	1,606
Reserves	2,73,090	3,19,360	4,02,165
Borrowings	34,180	0	0
	1,35,438	1,54,297	1,50,402
Total Liabilities	4,44,260	4,75,214	5,54,173
	1,92,542	1,88,329	1,79,645
CWIP	7,606	6,170	7,380
	53,123	48,796	90,781
	1,90,988	2,31,918	2,76,367
Total Assets	4,44,260	4,75,214	5,54,173

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2024	Mar 2025	Mar 2026
	78,903	88,403	64,489
Cash from Investing Activity	-41,245	-28,993	-58,721
Cash from Financing Activity	-37,408	-57,427	-10,768
Net Cash Flow	250	1,984	-5,000
CFO/OP	86%	84%	58%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2024	Mar 2025	Mar 2026
Debtor Days	61	71	72
Inventory Days	45	48	54
Days Payable	91	104	113
Cash Conversion Cycle	16	14	14
ROCE %	25	27	24

Shareholding Pattern

Numbers in percentages

Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
53.77	53.74	53.66	47.84	47.73	47.56	47.55	48.80
12.17	13.61	14.63	18.29	17.77	15.31	14.88	16.33
17.61	16.80	16.40	18.71	19.62	22.83	23.35	21.38
0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00
16.43	15.82	15.29	15.14	14.88	14.30	14.22	13.48

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-07-13

Suspension of Trading

2026-07-13 - Members of the Exchange are hereby informed that the trading in equity shares of JB Chemicals & Pharmaceuticals Limited shall be suspended w.e.f. July 17, 2026 (i.e., closing hours of trading on July 16, 2026) on account of the Scheme of Amalgamation.

2026-07-08

General Updates

2026-07-08 - JB Chemicals & Pharmaceuticals Limited has informed the Exchange about General Updates

2026-07-07

Certificate under SEBI (Depositories and Participants) Regulations, 2018

2026-07-07 - JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

2026-07-07

Record Date

2026-07-07 - JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Merger/HiveOff is 17-Jul-2026.

2026-07-07

General Updates

2026-07-07 - JB Chemicals & Pharmaceuticals Limited has informed the Exchange about General Updates

2026-07-06

General Updates

2026-07-06 - JB Chemicals & Pharmaceuticals Limited has informed the Exchange about General Updates

2026-07-01

Disclosure under SEBI Takeover Regulations

2026-07-01 - Torrent Pharmaceuticals Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

2026-06-30

Trading Window

2026-06-30 - JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

2026-06-30

Retirement

2026-06-30 - JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Change in Senior Management Personnel

News

Recent coverage and analyst commentary for JBCHEPHARM

Loading news…

🤖

AI Stock Analyst

JB Chemicals & Pharmaceuticals Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

Sun Pharmaceutical Industries Ltd.

1950.00

40.76

467870.32

0.82

2709.66

25.80

14611.79

12.76

19.11

26.97

Divi's Laboratories Ltd.

7319.75

75.67

194316.36

0.41

751.00

13.44

2831.00

9.52

21.51

32.99

Torrent Pharmaceuticals Ltd.

5002.75

78.26

169315.79

0.76

364.00

-26.91

4197.00

41.84

19.27

32.31

Cipla Ltd.

1429.45

29.77

115477.45

0.91

542.51

-55.32

6541.20

-2.80

16.00

15.13

Zydus Lifesciences Ltd.

1153.50

22.83

115062.07

0.09

1341.00

7.82

7587.00

16.22

21.39

25.16

Lupin Ltd.

2500.05

21.44

114311.01

0.72

1468.67

87.72

7474.66

31.89

28.86

33.25

Mankind Pharma Ltd.

2545.00

54.95

105107.48

0.00

559.42

31.74

3442.93

11.81

13.24

27.10

Dr. Reddy's Laboratories Ltd.

1223.90

24.35

102155.97

0.65

221.30

-86.05

7546.40

-11.51

13.75

5.13

Aurobindo Pharma Ltd.

1548.10

25.42

89074.25

0.26

920.84

1.99

8853.34

5.62

14.39

19.77

Laurus Labs Ltd.

1557.60

94.68

84149.28

0.13

282.09

21.19

1811.57

5.31

18.20

28.28

Biocon Ltd.

440.70

186.26

71820.62

0.11

198.60

-56.77

4516.60

2.25

3.26

22.59

Alkem Laboratories Ltd.

5703.50

29.63

68193.90

0.93

251.11

-22.11

3603.32

14.62

21.56

14.34

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Sales

1,004

1,001

963

949

1,094

1,085

1,065

904

724

730

709

723

793

775

769

703

Operating Profit

280

271

255

226

301

310

296

201

OPM %

28%

27%

26%

24%

28%

29%

28%

22%

-15

Interest

Depreciation

Profit before tax

240

237

218

193

272

279

267

135

Tax %

26%

25%

26%

25%

Net Profit

177

175

162

146

202

208

198

101

EPS in Rs

11.39

11.24

10.45

9.36

12.96

13.27

12.63

6.31

Mar 2024

Mar 2025

Mar 2026

Sales

3,29,864

3,72,292

3,88,989

2,42,157

2,70,765

2,83,794

Operating Profit

87,708

1,01,527

1,05,195

OPM %

27%

3,702

3,740

5,923

Interest

4,052

912

459

Depreciation

13,524

16,645

17,669

Profit before tax

73,834

87,711

90,273

Tax %

26%

25%

Net Profit

54,336

65,254

67,410

EPS in Rs

35.07

42.00

42.91

Mar 2024

Mar 2025

Mar 2026

Equity Capital

1,552

1,557

1,606

Reserves

2,73,090

3,19,360

4,02,165

Borrowings

34,180

1,35,438

1,54,297

1,50,402

Total Liabilities

4,44,260

4,75,214

5,54,173

1,92,542

1,88,329

1,79,645

CWIP

7,606

6,170

7,380

53,123

48,796

90,781

1,90,988

2,31,918

2,76,367

Total Assets

4,44,260

4,75,214

5,54,173

Mar 2024

Mar 2025

Mar 2026

78,903

88,403

64,489

Cash from Investing Activity

-41,245

-28,993

-58,721

Cash from Financing Activity

-37,408

-57,427

-10,768

Net Cash Flow

250

1,984

-5,000

CFO/OP

86%

84%

58%

Mar 2024

Mar 2025

Mar 2026

Debtor Days

Inventory Days

Days Payable

104

113

Cash Conversion Cycle

ROCE %

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

53.77

53.74

53.66

47.84

47.73

47.56

47.55

48.80

12.17

13.61

14.63

18.29

17.77

15.31

14.88

16.33

17.61

16.80

16.40

18.71

19.62

22.83

23.35

21.38

0.00

0.01

0.00

16.43

15.82

15.29

15.14

14.88

14.30

14.22

13.48

JB Chemicals & Pharmaceuticals Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

JB Chemicals & Pharmaceuticals Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI